Gate2Brain
  • Home
  • Company
    • Mission & vision
    • Awards & Recognitions
    • Seals & Product Designations
    • Supported by
  • About us
    • Founders
    • Team
    • Advisory board
    • Values
  • Technology
    • Scientific Publications
  • Pipeline-Proof of Concept
  • Investors
  • ESG
  • News & Media
  • Contact
  • Menu Menu

Gate2Brain in Transfiere – European Forum for Science, Technology & Innovation

Events
Next Wednesday, February 16, @Gate2Brain will be in #Transfiere, European Forum for Science, Technology and Innovation to be held in Malaga. Our CEO, @Meritxell Teixidó, will participate as a speaker together with 16 other companies, at the #Boosting Zone for being one of the companies that have been awarded the #NEOTEC2021 program of the @CDTI, Centro para el Desarrollo Tecnológico Industrial. Boosting Zone is a space for promoting innovation and technology transfer from scientific-based companies.Transfiere

Next Wednesday, February 16, Gate2Brain will be in Transfiere, European Forum for Science, Technology and Innovation to be held in Malaga.

Our CEO, Meritxell Teixidó, will participate as a speaker together with 16 other companies, at the Boosting Zone for being one of the companies that have been awarded the NEOTEC 2021 program of the CDTI, Centro para el Desarrollo Tecnológico Industrial. Boosting Zone is a space for promoting innovation and technology transfer from scientific-based companies.

February 14, 2022/by noticias
Tags: Biotech, BoostingZone, CasosdeÉxito, Innovation, medicinesbeyondbarriers, NEOTEC, technology, transfiere2022
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
  • Share by Mail
https://gate2brain.com/wp-content/uploads/2022/02/Anadir-un-subtitulo.jpg 1080 1080 noticias https://gate2brain.com/wp-content/uploads/2020/12/Logo-Gate1Brain500pxGrueso.png noticias2022-02-14 18:48:372022-02-14 19:08:09Gate2Brain in Transfiere – European Forum for Science, Technology & Innovation
You might also like
PaidhosGate2Brain wants to deliver drugs to the brain to combat intact barrier brain tumors, such as DIPG
Gate2Brain part of the CDTI’s NEOTEC program
G2B receives funding to accelerate its transfer to the market and society
Grit International Female Accelerator!Grit International Female AcceleratorG2B joined the Grit International Female Accelerator
Many drugs do not reach the brain and Gate2Brain technology helps to overcome that bottleneck
Gate2Brain among the 20 BioTech Startups to Watch in 2024
Nadia Calviño, First Vice President of the Government and Minister of Economic Affairs visits Gate2BrainSJDNadia Calviño, First Vice President of the Government visits Gate2Brain
10 Top Biotech Startups to Watch in 2023StartUs10 Top Biotech Startups to Watch in 2023

CATEGORIES

  • Advisory Board
  • Events
  • Funding & Breakthroughs
  • Interviews
  • Media & Press
  • Media Coverage
  • News
  • Podcasts
  • Press releases
  • Research & Publications
  • Sin categoría
  • Video Content

Events

  • Gate2Brain to Participate in the Barcelona Deep Tech Summit 2025November 3, 2025 - 10:23
  • Gate2Brain at BioJapan 2025 — Enabling Innovative Brain Delivery SolutionsOctober 15, 2025 - 12:56
  • Gate2Brain turns 5!July 9, 2025 - 18:07
  • Bioengineering the Future of Drug Delivery workshop – PortoApril 8, 2025 - 10:03
  • Gate2Brain at the 2nd Peptide-Based Therapeutics Summit | BostonMarch 26, 2025 - 15:34

SOCIAL

  • linkedin
  • youtube
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

  • linkedin
  • youtube
© Copyright –Edisenius
  • Privacy Policy
  • Legal Notice
  • Cookie Policy
How to transport drugs to the brain to treat pathologies?¿Cómo transportar fármacos al cerebro para tratar patologías?La Vanguardiadoctorat industrialAn industrial doctorate is looking to transport drugs to the brain to treat...
Scroll to top
Manage Cookie Consent
This Website uses proprietary and third-party cookies to improve services and facilitate browsing. You can obtain further information about the cookies this site uses and how to limit them in the
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}